LETTER TO THE EDITOR
Prognostic impact of circulating tumor cells in patients with soft-tissue sarcomas: a prospective study
Julie Blanchi, Audrey Laroche-Clary, Fran?ois Le Loarer, Benjamin Bonhomme, Antoine Italiano
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 2/3/2023 doi:10.1002/cac2.12389
LETTER TO THE EDITOR
Impact of small molecule-mediated inhibition of ammonia detoxification on lung malignancies and liver metabolism
Georgios Makris, Semih Kayhan, Marvin Kreuzer, Véronique Rüfenacht, Erica Faccin, Jarl Underhaug, Carmen Diez-Fernandez, Philip A. Knobel, Martin Poms, Nadine Gougeard, Vicente Rubio, Aurora Martinez, Martin Pruschy, Johannes H?berle
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/28/2023 doi:10.1002/cac2.12402
LETTER TO THE EDITOR
A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer
Tatiana Shaurova, Lingyue Yan, Yafei Su, Laurie James Rich, Vui King Vincent-Chong, Hannah Calkins, Saraswati Pokharel, Martin Petkovich, Mukund Seshadri, Yun Wu, Pamela Anne Hershberger
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/24/2023 doi:10.1002/cac2.12401
LETTER TO THE EDITOR
Combination of photodynamic therapy and stimulator of interferon genes (STING) agonist inhibits colorectal tumor growth and recurrence
Yang Hao, Sen Ma, Zili Gu, Alireza Haghparast, Timo Schomann, Zhenfeng Yu, Yuanyuan He, Xiaoxv Dong, Luis J Cruz, Peter ten Dijke
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/23/2023 doi:10.1002/cac2.12405
EDITORIAL
Criteria and regulatory considerations for the conditional approval of innovative antitumor drugs in China: from the perspective of clinical reviewers
Limin Zou, Yueli Qi, Yongling Jiang, Ling Tang, Yu Du, Boyuan Zhao, Yanzhe Sun, Meiyi Xiang, Jun Ma, Zhimin Yang
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/22/2023 doi:10.1002/cac2.12400
LETTER TO THE EDITOR
Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer
Stephen Keelan, Mihaela Ola, Sara Charmsaz, Sinéad Cocchiglia, Daniela Ottaviani, Seán Hickey, Siobhan Purcell, Fiona Bane, Aisling Hegarty, Ben Doherty, Katherine Sheehan, Lance Hudson, Nicola Cosgrove, Benjamin Roux, Muriel Laine, Geoffrey Greene, Damir
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/20/2023 doi:10.1002/cac2.12407
LETTER TO THE EDITOR
Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study
Satoru Iwasa, Zi-Xian Wang, Kei Muro, Satoshi Morita, Young Suk Park, Dongsheng Zhang, Yasuhide Yamada, Junichi Sakamoto, Tae Won Kim
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/16/2023 doi:10.1002/cac2.12406
RESEARCH HIGHLIGHT
Aerobic glycolysis promotes tumor immune evasion and tumor cell stemness through the noncanonical function of hexokinase 2
Haiyan He, Liwei Xiao, Juhong Wang, Dong Guo, Zhimin Lu
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/5/2023 doi:10.1002/cac2.12404
ORIGINAL ARTICLE
METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
Peng Xia, Hao Zhang, Haofeng Lu, Kequan Xu, Xiang Jiang, Yuke Jiang, Xiangdong Gongye, Zhang Chen, Jie Liu, Xi Chen, Weijie Ma, Zhonglin Zhang, Yufeng Yuan
Cancer Communications 2023 43: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 1/5/2023 doi:10.1002/cac2.12403
REVIEW
Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors
Farhoodeh Ghaedrahmati, Nafiseh Esmaeil, Maryam Abbaspour
Cancer Communications 2022 42: [ PDF Full-text ] [ HTML Full-text ] [ PubMed] Epub: 12/30/2022 doi:10.1002/cac2.12394
